Pnc Financial Services Group, Inc. Arbutus Biopharma Corp Transaction History
Pnc Financial Services Group, Inc.
- $150 Billion
- Q2 2024
A detailed history of Pnc Financial Services Group, Inc. transactions in Arbutus Biopharma Corp stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 664 shares of ABUS stock, worth $2,556. This represents 0.0% of its overall portfolio holdings.
Number of Shares
664
Previous 208
219.23%
Holding current value
$2,556
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding ABUS
# of Institutions
138Shares Held
95.5MCall Options Held
3.44MPut Options Held
377K-
Morgan Stanley New York, NY21MShares$80.7 Million0.01% of portfolio
-
Whitefort Capital Management, LP New York, NY12.9MShares$49.5 Million30.08% of portfolio
-
Black Rock Inc. New York, NY11.6MShares$44.5 Million0.0% of portfolio
-
Two Seas Capital LP Rye, NY8.57MShares$33 Million10.59% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.02MShares$27 Million0.0% of portfolio
About Arbutus Biopharma Corp
- Ticker ABUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 149,951,008
- Market Cap $577M
- Description
- Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...